FDA.reportPublic FDA data

NMNPQQ

Manufacturer
Golden Life Health Products Limited
Effective date
2020-12-23
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 23:35:49

Label at a glance#

ProductNMNPQQ
Active ingredientPYRROLOQUINOLINEDIONE TRICARBOXYLIC ACID, NICOTINAMIDE RIBOTIDE
Label structure9 sections

Label contents#

Full prescribing information#

DOSAGE & ADMINISTRATION SECTION

serving Two capsule per day after meal.
Usual adult usage: Six capsules maximum in 24 hours ifneeded. Do not exceed the limitation.

information

HEPATIC IMPAIRMENT SUBSECTION

Keep tightly closed, Protect from light.
Store at Refrigerator is recommended. Store at controlled room temperature between 20℃ to 25 ℃ celsius or 68°F to 77°F Fahrenheit

INDICATIONS & USAGE SECTION

This product is not recommended for cancer patients,pregnant women, and people age below 18 years oldbased on scientific research. lf you have any questions,please consult doctors or professionals for more information.

INACTIVE INGREDIENT SECTION

Resveraltrol

OTC - ACTIVE INGREDIENT SECTION

Nicotinamide mononucleotide 200mg 45%

pyrroloquinoline quinone 50mg 10%

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of children's reach.

OTC - PURPOSE SECTION

Every capsule contains
200mg Nicotinamide Mononucleotide for NAD+ Support.
50mg Pyrroloquinoline Quinone Enzymefor Mitochondrion Support

WARNINGS SECTION

Sealed for safety and freshness free of artificial colors,preservatives , or sweeteners, No dairy, starch, wheat,gluten, yeast, soil, corn, egg tree nuts, or GMOs.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

labellabel

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
11777-001-012022-01-28C16284748780-1d6a99b39-80f5-a426-e053-dadaa90af4c2b71f4e72-0e79-f1ec-e053-2a95a90a5126

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
11777-001-01NMNPQQ60 in 1 PACKAGEPOWDER601
11777-001-01NMNPQQ1 mg in 1 CAPSULEPOWDER11

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
11777-001NMNPQQ POWDER [GOLDEN LIFE HEALTH PRODUCTS LIMITED]1Legacy NDC, 2 package rows20201224_b71f4e72-0e79-f1ec-e053-2a95a90a5126.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 4 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
11777-00111777-001-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Name, UNII, Kind table
NameUNIIKind
PYRROLOQUINOLINEDIONE TRICARBOXYLIC ACID47819QGH5LACTIB
NICOTINAMIDE RIBOTIDE2KG6QX4W0VACTIB
RESVERATROLQ369O8926LIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
b71f4e72-0e7a-f1ec-e053-2a95a90a5126b71f4e72-0e79-f1ec-e053-2a95a90a51262020-12-23WarningsExact identifier
spl id: b71f4e72-0e7a-f1ec-e053-2a95a90a5126
spl set id: b71f4e72-0e79-f1ec-e053-2a95a90a5126

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.